The Effect Of A Controlled Daily Skin Care Regimen On Retinoic Acid Tolerance
NCT00440024 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2020-03-13
Summary
Sun-damaged skin, caused by chronic exposure to ultraviolet (UV) light, is characterized by features such as wrinkling, uneven skin color, roughness and brown spots. An effective treatment for sun-damage that is commonly prescribed is topical retinoic acid (RA). However, the major drawback of topical RA use has been frequently observed irritation characterized by redness, dry skin and severe itching. In this study, we examine whether a daily skin care regimen comprised of an ultra mild cleanser and an effective moisturizer can help improve tolerance to RA treatment.
Conditions
- Sun-Damaged Skin
- Retinoid Intolerance
Interventions
- DRUG
-
Tazorac
Tazarotene 0.1% cream applied to the face once daily before bed
- DRUG
-
Dove Mild Cleanser
Ultra mild cleanser: Dove Non-foaming cleansing lotion
- DRUG
-
Dove Facial Moisturizer
Moisturizing cream - Dove facial moisturizer with SPF 15
Sponsors & Collaborators
-
Unilever R&D
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Dana Sachs, MD · University of Michigan
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 40 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2009-11-30
- Completion
- 2009-11-30
Countries
- United States
Study Locations
More Related Trials
-
Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris
NCT00835198 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris
NCT02886715 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety Profile, and Post-Acne Sequelae of 0.025% Retinoic Acid Cream vs. 0.1% Adapalene Cream in Mild Acne Vulgaris in Fitzpatrick Skin Types III-V
NCT07015931 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris
NCT04724473 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products
NCT01313728 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris
NCT03341910 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris
NCT02525822 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris
NCT02938494 ·Status: COMPLETED ·Phase: PHASE2
-
Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac Cream
NCT02849873 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris
NCT03433378 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers
NCT01915758 ·Status: COMPLETED ·Phase: PHASE1
-
Retinyl Palmitate-loaded Ethosomes in Acne Vulgaris
NCT04080869 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris
NCT02411955 ·Status: COMPLETED ·Phase: PHASE1
-
4 Week In-Use Study Evaluating How Well-Tolerated a Skin Care Product Is on Adults With Facial Redness
NCT03841032 ·Status: COMPLETED ·Phase: NA
-
A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris
NCT03599193 ·Status: COMPLETED ·Phase: PHASE2
-
Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne
NCT05704114 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Oral Isotretinoin for Cutaneous Photodamage
NCT00842907 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation
NCT03926845 ·Status: COMPLETED ·Phase: NA
-
Topical PDT Cream Without Irradiation Source in the Acne Treatment
NCT02313467 ·Status: COMPLETED ·Phase: NA
-
Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses
NCT00756288 ·Status: WITHDRAWN ·Phase: NA
-
To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris
NCT03427554 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention
NCT03642535 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash
NCT00891982 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers.
NCT01119651 ·Status: COMPLETED ·Phase: PHASE1
-
Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris
NCT00834210 ·Status: COMPLETED ·Phase: PHASE4